Dani Zhong

Nanning, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

First-Line treatment for transplant-ineligible newly diagnosed multiple myeloma: a Bayesian network meta-analysis of efficacy, safety, and high-risk subgroups.

First-Line treatment for transplant-ineligible newly diagnosed multiple myeloma: a Bayesian network meta-analysis of efficacy, safety, and high-risk subgroups.

Journal: Frontiers in immunology
Published: April 30, 2026

Zanubrutinib plus salvage chemotherapy in patients with refractory/relapsed diffuse large B-cell lymphoma non-candidate for autologous stem cell transplantation: A retrospective study.

Zanubrutinib plus salvage chemotherapy in patients with refractory/relapsed diffuse large B-cell lymphoma non-candidate for autologous stem cell transplantation: A retrospective study.

Journal: Annals of hematology
Published: May 29, 2025

Dendritic cell vaccines: Current research progress, challenges, and opportunities.

Dendritic cell vaccines: Current research progress, challenges, and opportunities.

Journal: Genes & diseases
Published: March 13, 2025

Correction: Long non-coding RNA SNHG17 may function as a competitive endogenous RNA in diffuse large B-cell lymphoma progression by sponging miR-34a-5p.

Correction: Long non-coding RNA SNHG17 may function as a competitive endogenous RNA in diffuse large B-cell lymphoma progression by sponging miR-34a-5p.

Journal: PloS one
Published: December 31, 2024

Comparison of the Efficacy and Safety of Axi-Cel and Tisa-Cel Based on Meta-Analysis.

Comparison of the Efficacy and Safety of Axi-Cel and Tisa-Cel Based on Meta-Analysis.

Journal: Journal of Cancer
Published: June 08, 2024

A nanobody-guided multifunctional T cell engager promotes strong anti-tumor responses via synergistic immuno-photothermal effects.

A nanobody-guided multifunctional T cell engager promotes strong anti-tumor responses via synergistic immuno-photothermal effects.

Journal: Journal of nanobiotechnology
Published: April 30, 2024

Long non-coding RNA SNHG17 may function as a competitive endogenous RNA in diffuse large B-cell lymphoma progression by sponging miR-34a-5p.

Long non-coding RNA SNHG17 may function as a competitive endogenous RNA in diffuse large B-cell lymphoma progression by sponging miR-34a-5p.

Journal: PloS one
Published: June 19, 2023

Nanobody-based CAR T cells targeting intracellular tumor antigens.

Nanobody-based CAR T cells targeting intracellular tumor antigens.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 18, 2022

A Single-Chain Variable Fragment Antibody/Chemokine Fusion Protein Targeting Human Endoglin to Enhance the Anti-Tumor Activity of Cytokine-Induced Killer Cells.

A Single-Chain Variable Fragment Antibody/Chemokine Fusion Protein Targeting Human Endoglin to Enhance the Anti-Tumor Activity of Cytokine-Induced Killer Cells.

Journal: Journal of biomedical nanotechnology
Published: September 21, 2021

Single-Domain Antibody-Based TCR-Like CAR-T: A Potential Cancer Therapy.

Single-Domain Antibody-Based TCR-Like CAR-T: A Potential Cancer Therapy.

Journal: Journal of immunology research
Published: May 30, 2020

Aberrant promoter methylation profiles and association with survival in patients with hepatocellular carcinoma.

Aberrant promoter methylation profiles and association with survival in patients with hepatocellular carcinoma.

Journal: OncoTargets and therapy
Published: May 17, 2017

The hOGG1Ser326Cys polymorphism and increased lung cancer susceptibility in Caucasians: an updated meta-analysis.

The hOGG1Ser326Cys polymorphism and increased lung cancer susceptibility in Caucasians: an updated meta-analysis.

Journal: Scientific reports
Published: January 26, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026